CLDN5 is also identified as an aberrant methylation target in pancreatic carcinoma [142], as well as CLDN6 in breast and esophageal squamous cell carcinoma [143,144], and CLDN7 in breast ductal [145] and colorectal carcinoma [146]. The gene discussed is CLDN7; the disease is esophageal squamous cell carcinoma.